Magnitude and Factors Associated with Cytopenia Among Children on Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Science, Sidama Region, Southern Ethiopia

References

• UNAIDS. Report. Retrieved February; 2021.
   Google Scholar
• Rudnicka D. Intrusive HIV-1-infected cells. Nat Immunol. 2009;10:933–934. doi:10.1038/ni0909-933
   PubMed Web of Science ®Google Scholar
• Anastos K, Shi Q, French AL, et al. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1–infected women receiving highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2004;35(4):383–392. doi:10.1097/00126334-200404010-00008
   PubMed Web of Science ®Google Scholar
• Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies include pathomechanisms, novel differential diagnoses, and treatment. J Am Soc Hematol. 2014;124(15):2337–2344.
   Google Scholar
• Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci. 2009;16:1–7. doi:10.1186/1423-0127-16-102
   Web of Science ®Google Scholar
• Akinbami A, Oshinaike O, Adeyemo T, et al. Hematologic abnormalities in treatment-naive HIV patients. Infect Dis. 2010;3:S6033.
   Google Scholar
• Munyazesa E, Emile I, Mutimura E, et al. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study. BMJ open. 2012;2(6):e001600. doi:10.1136/bmjopen-2012-001600
   PubMed Web of Science ®Google Scholar
• Levine AM, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the women’s interagency HIV study. Arch Intern Med. 2006;166(4):405–410. doi:10.1001/archinte.166.4.405
   PubMedGoogle Scholar
• Jost J, Täuber MG, Lüthy R, Siegenthaler W. HIV-associated thrombocytopenia. Schweiz Med Wochenschr. 1988;118(6):206–212.
   PubMedGoogle Scholar
• Madec Y, Leroy S, Rey-Cuille MA, Huber F, Calmy A. Persistent difficulties in switching to second-line ART in sub-saharan Africa: a systematic review and meta-analysis. PLoS One. 2013;8(12):e82724. doi:10.1371/journal.pone.0082724
   PubMed Web of Science ®Google Scholar
• Melsew YA, Terefe MW, Tessema GA, Ayele TA. Rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at Debremarkos hospital, Northwest Ethiopia: a retrospective follow up study. Journal of AIDS Clinical Res. 2013;4:211.
   Google Scholar
• Wankah PN, Tagny CT, Mbanya DNS. Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon. BMC Hematology. 2014;14(1):1–6. doi:10.1186/2052-1839-14-15
   Google Scholar
• Bayleyegn B, Woldu B, Yalew A, Asrie F. Magnitude and associated factors of peripheral cytopenia among HIV-infected children attending University of Gondar Specialized Referral Hospital, Northwest Ethiopia. PLoS One. 2021;16(3):e0247878. doi:10.1371/journal.pone.0247878
   PubMed Web of Science ®Google Scholar
• Gathoni E, Nduati R, Wamalwa D, Kariuki N. Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS Res Ther. 2015;12:26. doi:10.1186/s12981-015-0069-4
   PubMed Web of Science ®Google Scholar
• Geletaw T, Zelalem M, Girma A. Hematologic abnormalities and associated factors among HIV infected children pre- and postantiretroviral treatment, North West Ethiopia. Doverss J Blood Med. 2017;8:99–105. doi:10.2147/JBM.S137067
   PubMed Web of Science ®Google Scholar
• Tsegay YG, Tadele A, Addis Z, Alemu A, Melku M. Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children. HIV/AIDS. 2017;9:31.
   Google Scholar
• Egata G, Dereje B, Dessalegn G, Birhanu S. Prevalence of Anemia and associated factors among PHIVs attendants antiretroviral therapy clinics in public health institutions in Dire Dawa town, East Ethiopia. J Med Physiol Biophysics. 2016;22:565.
   Google Scholar
• Eunice N, Francis B, Julius K. Anemia in HIV-infected children: severity, types, and effect on response to HAART in Rural Uganda. BMC Pediatr. 2012;12:170. doi:10.1186/1471-2431-12-170
   PubMed Web of Science ®Google Scholar
• De Santis GC, Brunetta DM, Vilar FC, et al. Hematological abnormalities in HIV-infected patients. International Journal of Infectious Diseases. 2011;15(12):e808–11. doi:10.1016/j.ijid.2011.08.001
   PubMed Web of Science ®Google Scholar
• Debasu M, Menon M, Belayneh Y, Abebe W, Jerene D, Seifu D. Antiretroviral Treatment Related Haematological Disorders among HIV- Infected Children Attending HIV Clinic at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Int Blood Res Rev. 2015;4:11–18. doi:10.9734/IBRR/2015/20197
   Google Scholar
• Dikshit B, Wanchu A, Sachdeva K, Sharma A. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disorder. 2009;9:5.
   PubMedGoogle Scholar
• Ahumareze RE, Rankin J, David A, et al. Prevalence of anaemia and the relationship between haemoglobin concentration and CD4 count in HIV positive children on highly active antiretroviral therapy (HAART) in Lagos, Nigeria. Curr Pediatric Res. 2016;1:t5.
   Google Scholar
• Quaye W, Addai-Mensah A. Prevalence of anemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11:1.
   Web of Science ®Google Scholar
• Ako S, Njunda L, Akum E, Benjamin P, Assob J. Hematological Related Disorders and Transfusion of HIV Patients on Highly Active Antiretroviral Therapy (HAART) in the South West Region of Cameroon: hematological Monitory Parameters for HIV Follow-Up. J HIV Retrovirus. 2018;4(1):5.
   Google Scholar
• Tsegay YG, Tadele A, Addis Z, Alemu A, Melku M. Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children. HIV/AIDS (Auckland, NZ. 2017;9:31.
   PubMed Web of Science ®Google Scholar
• Coutsoudis A, Coovadia H, Kindra G. Time for new recommendations on co-trimoxazole prophylaxis for HIV-exposed infants in developing countries? Bulletin of the World Health Organization. Bulletin of the World Health Organization. 2010;88(12):949–950. doi:10.2471/BLT.10.076422
   PubMedGoogle Scholar
• Mehta S, Jutur S, Gautam D. Hematologic Manifestations of HIV/AIDS. Med Update. 2011;484–490.
   Google Scholar
• Adetifa IMO, Temiye E, Akinsulie A, Ezeaka V, Iroha E. Haematological abnormalities associated with pediatric HIV/AIDS in Lagos. Ann Trop Paediatr. 2006;26:121–125. doi:10.1179/146532806X107467
   PubMed Web of Science ®Google Scholar
• Muluneh A, Fessahaye A. hematologic abnormalities among children on HAART among Jimma university specialized hospital, southwestern Ethiopia. Ethiopian Health Science Journal. 2009;19(2):83–89.
   Google Scholar
• Madzivire M, Chimhini G, Chikwasha V, Mandisodza A. Haematological features in Paediatric patients on second line Highly Active Antiretroviral Therapy in Zimbabwe. J Med. 2018;3:9.
   Google Scholar
• Kibaru EG, Nduati R, Wamalwa D, Kariuki N. Baseline hematological indices among HIV-1 infected children at Kenyatta National Hospital. Int J Novel Res Healthcare Nursing. 2014;1(1):21–26.
   Google Scholar
• Shah I, Katira B. Hematological manifestation in HAART naïve HIV-1 infected children in India in a resource-limited setting. Pediatric Oncall J. 2011;8(5):35.
   Google Scholar
• Bhowmik A, Banerjee P. Hematological manifestation in HIV infected children. J Coll Physicians Surg. 2015;25(2):119–123.
   PubMed Web of Science ®Google Scholar
• Poudel P, Pokharel R, Chitlangia M, Chaudhary S. Profile of HIV infected children: a hospital-based study at Eastern Nepal. Asian Pac J Trop Dis. 2014;4(3):169–175. doi:10.1016/S2222-1808(14)60499-0
   Google Scholar
• Kumar D, Kumar D, Singh DK. Prevalence of thrombocytopenia and its relation with WHO clinical and immunological staging among human immunodeficiency virus-infected children. Indian J Child Health. 2014;1(3):140–142. doi:10.32677/IJCH.2014.v01.i03.010
   Google Scholar
• Kibaru EG, Nduati R, Wamalwa D, Kariuki N. Baseline hematological indices among HIV-1 infected children at Kenyatta National Hospital. Int J Novel Res Healthcare Nursing. 2014;1(1):21–26.
   Google Scholar
• Nyesigire Ruhinda E, Bajunirwe F, Kiwanuka J. Anaemia in HIV-infected children: severity, types, and effect on response to HAART. BMC Pediatr. 2012;12(1):1–6.
   PubMedGoogle Scholar
• Shet A, Bhavani P, Kumarasamy N, et al. Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study. BMC Pediatr. 2015;15(1):1–9. doi:10.1186/s12887-015-0484-7
   PubMedGoogle Scholar
• Fenta DA, Wube TB, Nuru MM. Hematological and immunological abnormalities among children receiving highly active antiretroviral therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia. Res Square. 2020:453.
   Google Scholar